Michael Little, Ph.D.
I became a senior advisor for Popper and Company in July 2014 following a long tenure in senior executive roles in the in vitro diagnostic (IVD) and companion diagnostic (CDx) industries. I bring to the team not only strong technical experience and a track record in developing and launching products in both industries, but I also have significant experience in building technical organizations, developing leaders in technical organizations, and, when required, facilitating turn-arounds of these organizations. I offer our clients my experience-based, practical, integrated, and proven means of achieving business goals.
I have 27 years’ experience in biotech and diagnostics, with a background in functions ranging from research to full commercialization. I have had the opportunity to develop diagnostic technology in a research setting, to take it through full FDA-regulated development and launch, and to manage the ensuing molecular business from the initial technology (BD Diagnostics). This experience served me well in later roles, including at a start-up as Chief Operating Officer (Adlyfe), and as the VP/Global Head of Diagnostics Development in companion diagnostics focused on personalized medicine (Novartis).
I have two adult sons and enjoy spending as much time as possible with them. I also am an athlete and love weightlifting and mountain bike riding. I have a Ph.D. in Microbiology from the University of Florida and completed post-doctoral studies in the molecular biology of chloroplast transcription at the University of Arizona.